Ake should start trading on it's in valuation merits soon irrespective of what livent is doing overseas. pe is now about 6 on EV assuming $1bn in cash not included. That's bloody cheap for a non dividend paying stock
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%